Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stock Ready To Explode!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Cytosorbents Corporation (CTSO) Stock Breakout Alert: How to Trade Now?

Cytosorbents Corporation (NASDAQ:CTSO) jumped 17.50% after the FDA approved the company’s Investigational Device Exemption request for DrugSorb-ATR Antithrombotic Removal (ATR) device. With the approval, the company can now move forward with START-T clinical trials evaluating the device in the US for removal of intraoperative ticagrelor during cardiothoracic operation. The company will conduct the study under …